chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patients vaccinated using old vial from 03/10/21; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients vaccinated using old vial from 03/10/21) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients vaccinated using old vial from 03/10/21). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients vaccinated using old vial from 03/10/21) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter No treatment information was provided   This case was linked to MOD-2021-208074, MOD-2021-258552, MOD-2021-258572, MOD-2021-258587, MOD-2021-258599, MOD-2021-258615, MOD-2021-258632, MOD-2021-258644, MOD-2021-258660, MOD-2021-258672, MOD-2021-258682, MOD-2021-258689, MOD-2021-258691, MOD-2021-258693, MOD-2021-258697, MOD-2021-258699, MOD-2021-258700, MOD-2021-258702, MOD-2021-258703, MOD-2021-207548 (Patient Link).
Age: 31.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received a dose from a punctured vial after the 12 hour timeframe in the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a dose from a punctured vial after the 12 hour timeframe in the refrigerator) in a 31-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a dose from a punctured vial after the 12 hour timeframe in the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received a dose from a punctured vial after the 12 hour timeframe in the refrigerator) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant product reported by reporter. No treatment medication reported by reporter. Consent given for Safety to follow up. Email provided for contact.   This case was linked to MOD-2021-208074, MOD-2021-207584, MOD-2021-258552, MOD-2021-258572, MOD-2021-258587, MOD-2021-258599, MOD-2021-258615, MOD-2021-258632, MOD-2021-258644, MOD-2021-258660, MOD-2021-258672, MOD-2021-258682, MOD-2021-258689, MOD-2021-258691, MOD-2021-258693, MOD-2021-258697, MOD-2021-258699, MOD-2021-258700, MOD-2021-258702, MOD-2021-258704, MOD-2021-258706 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Pyrexia, Skin burning sensation, Urticaria
Clinical narrative: Itching hives; Felt like was burning out her skin; Painful hives; Burning hives/Big hives that covered whole body from head to toe; fever; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching hives), SKIN BURNING SENSATION (Felt like was burning out her skin), PAIN (Painful hives), URTICARIA (Burning hives/Big hives that covered whole body from head to toe) and PYREXIA (fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergy to Lidocaine reaction: heart rate increase.) and Anesthesia (Once trouble waking up and another time woke up prematurely).    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching hives), SKIN BURNING SENSATION (Felt like was burning out her skin), PAIN (Painful hives), URTICARIA (Burning hives/Big hives that covered whole body from head to toe) and PYREXIA (fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching hives), SKIN BURNING SENSATION (Felt like was burning out her skin), PAIN (Painful hives), URTICARIA (Burning hives/Big hives that covered whole body from head to toe) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was taking other medication.  Treatment medication included Benadryl, but did not help.   Most recent FOLLOW-UP information incorporated above includes: On 13-Aug-2021: Follow up received: Added patient height and weight, medical history, new events. Updated out come of the events from unknown to recovered/resolved.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Peripheral swelling
Clinical narrative: Neck pain; Swollen arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NECK PAIN (Neck pain) and PERIPHERAL SWELLING (Swollen arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included Gastric bypass. Concurrent medical conditions included Spinal stenosis.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced NECK PAIN (Neck pain) and PERIPHERAL SWELLING (Swollen arm). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form three times a day. On 23-Mar-2021, NECK PAIN (Neck pain) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication reported. treatment information includes steroids.   This case was linked to MOD-2021-230030 (Patient Link).
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration, Vaccination site discolouration
Clinical narrative: dime sized bleached out mark were the tattoo was red in color; I have a bleached out spot on my tattoo where I got my second vaccine/ I  do not know of it bled so much it left that spot bare of ink or it was from the shot itself; could not maintain a normal temperature it fluctuated; flu-like symptoms; whole body aches; joints hurt; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (I have a bleached out spot on my tattoo where I got my second vaccine/ I  do not know of it bled so much it left that spot bare of ink or it was from the shot itself), BODY TEMPERATURE FLUCTUATION (could not maintain a normal temperature it fluctuated), INFLUENZA LIKE ILLNESS (flu-like symptoms), SKIN DISCOLOURATION (dime sized bleached out mark were the tattoo was red in color) and PAIN (whole body aches) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 078C21A and 050C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jul-2021, the patient experienced BODY TEMPERATURE FLUCTUATION (could not maintain a normal temperature it fluctuated), INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (whole body aches), ARTHRALGIA (joints hurt) and HEADACHE (headache). On 16-Jul-2021, the patient experienced VACCINATION SITE DISCOLOURATION (I have a bleached out spot on my tattoo where I got my second vaccine/ I  do not know of it bled so much it left that spot bare of ink or it was from the shot itself). On an unknown date, the patient experienced SKIN DISCOLOURATION (dime sized bleached out mark were the tattoo was red in color). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 17-Jul-2021, BODY TEMPERATURE FLUCTUATION (could not maintain a normal temperature it fluctuated), INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (whole body aches), ARTHRALGIA (joints hurt) and HEADACHE (headache) had resolved. At the time of the report, VACCINATION SITE DISCOLOURATION (I have a bleached out spot on my tattoo where I got my second vaccine/ I  do not know of it bled so much it left that spot bare of ink or it was from the shot itself) and SKIN DISCOLOURATION (dime sized bleached out mark were the tattoo was red in color) outcome was unknown.            No concomitant medications were provided.   This case was linked to MOD-2021-285512 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2021: Significant follow-up information contains: reporter details, patient age,gender and added events-pain, arthralgia, influenza like illness, headache, body temp fluctuations, erythema, vaccination site discoloration
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product was reported. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Decreased activity, Fatigue, Nasopharyngitis, Palpitations, Paraesthesia
Clinical narrative: In bed for 2 days; Feel "prickly"; heart is racing; Freezing cold; Severe fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED ACTIVITY (In bed for 2 days), PARAESTHESIA (Feel "prickly"), PALPITATIONS (heart is racing), NASOPHARYNGITIS (Freezing cold) and FATIGUE (Severe fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED ACTIVITY (In bed for 2 days), PARAESTHESIA (Feel "prickly"), PALPITATIONS (heart is racing), NASOPHARYNGITIS (Freezing cold), FATIGUE (Severe fatigue) and PYREXIA (Fever). At the time of the report, DECREASED ACTIVITY (In bed for 2 days), PARAESTHESIA (Feel "prickly"), PALPITATIONS (heart is racing), NASOPHARYNGITIS (Freezing cold), FATIGUE (Severe fatigue) and PYREXIA (Fever) outcome was unknown.            No relevant concomitant medications was reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: In bed for 2 days; Feel "prickly"; heart is racing; Freezing cold; Severe fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED ACTIVITY (In bed for 2 days), PARAESTHESIA (Feel "prickly"), PALPITATIONS (heart is racing), NASOPHARYNGITIS (Freezing cold) and FATIGUE (Severe fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED ACTIVITY (In bed for 2 days), PARAESTHESIA (Feel "prickly"), PALPITATIONS (heart is racing), NASOPHARYNGITIS (Freezing cold), FATIGUE (Severe fatigue) and PYREXIA (Fever). At the time of the report, DECREASED ACTIVITY (In bed for 2 days), PARAESTHESIA (Feel "prickly"), PALPITATIONS (heart is racing), NASOPHARYNGITIS (Freezing cold), FATIGUE (Severe fatigue) and PYREXIA (Fever) outcome was unknown.            No relevant concomitant medications was reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired Moderna Covid-19 vaccine administered to 7 patient's; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine administered to 7 patient's) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine administered to 7 patient's). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine administered to 7 patient's) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications was reported  No treatment information was provided   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow-up was received on 20-JUL-2021 Does not contains any new information
Sex: F
Vaccine: COVID19
Symptoms: Abnormal sensation in eye, Blood pressure measurement, Chills, Cough, Decreased appetite
Clinical narrative: Great appetite suppressant; Sweating off and on; fever started; coughing started as well; body ache/ arm soreness; eyes feel warm; face/ forehead warm; chills; This spontaneous case was reported by a consumer and describes the occurrence of ABNORMAL SENSATION IN EYE (eyes feel warm), FEELING HOT (face/ forehead warm), HYPERHIDROSIS (Sweating off and on), DECREASED APPETITE (Great appetite suppressant) and COUGH (coughing started as well) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced ABNORMAL SENSATION IN EYE (eyes feel warm), FEELING HOT (face/ forehead warm), MYALGIA (body ache/ arm soreness) and CHILLS (chills). On 20-May-2021, the patient experienced COUGH (coughing started as well) and PYREXIA (fever started). On 21-May-2021, the patient experienced HYPERHIDROSIS (Sweating off and on). On an unknown date, the patient experienced DECREASED APPETITE (Great appetite suppressant). At the time of the report, ABNORMAL SENSATION IN EYE (eyes feel warm), FEELING HOT (face/ forehead warm), HYPERHIDROSIS (Sweating off and on), DECREASED APPETITE (Great appetite suppressant), COUGH (coughing started as well), MYALGIA (body ache/ arm soreness), PYREXIA (fever started) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-May-2021, Blood pressure measurement: 123/82 mmHg 123/82 mmHg at 9:24am ,122/85mmHg at 9:40 am,117/88mmHg at 9:45pm. On 20-May-2021, Blood pressure measurement: 111/76 mmHg 114/74mmHg at 1:55 am ,100/72mmHg at 5:20 pm. On 21-May-2021, Blood pressure measurement: 110/76 mmHg 110/76mmHg at 2:55 am.         No concomitant and treatment medications were provided.   This case was linked to MOD-2021-127394 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: Great appetite suppressant; Sweating off and on; fever started; coughing started as well; body ache/ arm soreness; eyes feel warm; face/ forehead warm; chills; This spontaneous case was reported by a consumer and describes the occurrence of ABNORMAL SENSATION IN EYE (eyes feel warm), FEELING HOT (face/ forehead warm), HYPERHIDROSIS (Sweating off and on), DECREASED APPETITE (Great appetite suppressant) and COUGH (coughing started as well) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced ABNORMAL SENSATION IN EYE (eyes feel warm), FEELING HOT (face/ forehead warm), MYALGIA (body ache/ arm soreness) and CHILLS (chills). On 20-May-2021, the patient experienced COUGH (coughing started as well) and PYREXIA (fever started). On 21-May-2021, the patient experienced HYPERHIDROSIS (Sweating off and on). On an unknown date, the patient experienced DECREASED APPETITE (Great appetite suppressant). At the time of the report, ABNORMAL SENSATION IN EYE (eyes feel warm), FEELING HOT (face/ forehead warm), HYPERHIDROSIS (Sweating off and on), DECREASED APPETITE (Great appetite suppressant), COUGH (coughing started as well), MYALGIA (body ache/ arm soreness), PYREXIA (fever started) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-May-2021, Blood pressure measurement: 123/82 mmHg 123/82 mmHg at 9:24am ,122/85mmHg at 9:40 am,117/88mmHg at 9:45pm. On 20-May-2021, Blood pressure measurement: 111/76 mmHg 114/74mmHg at 1:55 am ,100/72mmHg at 5:20 pm. On 21-May-2021, Blood pressure measurement: 110/76 mmHg 110/76mmHg at 2:55 am.         No concomitant and treatment medications were provided.   This case was linked to MOD-2021-127394 (Patient Link).
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Decreased appetite, Dyspnoea, Fatigue, Hypoaesthesia
Clinical narrative: Feet numbness/ continue to have numbness of both feet; finger tingling begins/continue to have tingling in both hands; extreme  fatigue; Shortness of breath; no appetite; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), DECREASED APPETITE (no appetite), HYPOAESTHESIA (Feet numbness/ continue to have numbness of both feet), PARAESTHESIA (finger tingling begins/continue to have tingling in both hands) and FATIGUE (extreme  fatigue) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (Allergy to Penicillin).   On 17-Feb-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021 at 10:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced DYSPNOEA (Shortness of breath), DECREASED APPETITE (no appetite) and FATIGUE (extreme  fatigue). On 02-Apr-2021, the patient experienced HYPOAESTHESIA (Feet numbness/ continue to have numbness of both feet) and PARAESTHESIA (finger tingling begins/continue to have tingling in both hands). At the time of the report, DYSPNOEA (Shortness of breath), DECREASED APPETITE (no appetite) and FATIGUE (extreme  fatigue) outcome was unknown and HYPOAESTHESIA (Feet numbness/ continue to have numbness of both feet) and PARAESTHESIA (finger tingling begins/continue to have tingling in both hands) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood test: normal (normal) Favorable/ Normal. In 2021, SARS-CoV-2 antibody test: positive (Positive) Positive but patient believed to have exposed before dose 2.         It was reported that the patient was tested positive for COVID-19 antibodies, also reported that it might be before dose 2 No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.   This case was linked to MOD-2021-229613 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow-up received and contains significant information updated batch/lot number of vaccine On 26-Jul-2021: Follow-up received and contains no new information. On 10-Aug-2021: Follow up received and updated outcomes of events and lab data.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia, SARS-CoV-2 antibody test
Clinical narrative: Feet numbness/ continue to have numbness of both feet; finger tingling begins/continue to have tingling in both hands; extreme  fatigue; Shortness of breath; no appetite; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), DECREASED APPETITE (no appetite), HYPOAESTHESIA (Feet numbness/ continue to have numbness of both feet), PARAESTHESIA (finger tingling begins/continue to have tingling in both hands) and FATIGUE (extreme  fatigue) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (Allergy to Penicillin).   On 17-Feb-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021 at 10:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced DYSPNOEA (Shortness of breath), DECREASED APPETITE (no appetite) and FATIGUE (extreme  fatigue). On 02-Apr-2021, the patient experienced HYPOAESTHESIA (Feet numbness/ continue to have numbness of both feet) and PARAESTHESIA (finger tingling begins/continue to have tingling in both hands). At the time of the report, DYSPNOEA (Shortness of breath), DECREASED APPETITE (no appetite) and FATIGUE (extreme  fatigue) outcome was unknown and HYPOAESTHESIA (Feet numbness/ continue to have numbness of both feet) and PARAESTHESIA (finger tingling begins/continue to have tingling in both hands) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood test: normal (normal) Favorable/ Normal. In 2021, SARS-CoV-2 antibody test: positive (Positive) Positive but patient believed to have exposed before dose 2.         It was reported that the patient was tested positive for COVID-19 antibodies, also reported that it might be before dose 2 No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.   This case was linked to MOD-2021-229613 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow-up received and contains significant information updated batch/lot number of vaccine On 26-Jul-2021: Follow-up received and contains no new information. On 10-Aug-2021: Follow up received and updated outcomes of events and lab data.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Lethargy, Myalgia, Pain in extremity
Clinical narrative: lethargic; weakness; sore arm, really big and black and blue around it; muscle pain; felt wiped out, tired; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic), ASTHENIA (weakness), PAIN IN EXTREMITY (sore arm, really big and black and blue around it), MYALGIA (muscle pain) and FATIGUE (felt wiped out, tired) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: flu. Past adverse reactions to the above products included Pain in arm with flu.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced LETHARGY (lethargic), ASTHENIA (weakness), PAIN IN EXTREMITY (sore arm, really big and black and blue around it), MYALGIA (muscle pain) and FATIGUE (felt wiped out, tired). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, LETHARGY (lethargic), ASTHENIA (weakness), PAIN IN EXTREMITY (sore arm, really big and black and blue around it), MYALGIA (muscle pain) and FATIGUE (felt wiped out, tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Concomitant Medication was provided   This case was linked to MOD-2021-262346 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A and 035C21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: FLU.   On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 15-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.            No concomitant medications were reported.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   This case was linked to MOD-2021-262311 (Patient Link).
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Muscular weakness
Clinical narrative: Had all the general side effects listed for the last 2-3 days; Stiffness throughout body; Weakness in the entire arm on injection side.; low grade fever; Chills; Nausea; Fatigue; Headache; General muscle pain; Joint pain; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had all the general side effects listed for the last 2-3 days), MUSCULOSKELETAL STIFFNESS (Stiffness throughout body), MUSCULAR WEAKNESS (Weakness in the entire arm on injection side.), PYREXIA (low grade fever) and CHILLS (Chills) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21CA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness throughout body), MUSCULAR WEAKNESS (Weakness in the entire arm on injection side.), PYREXIA (low grade fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (General muscle pain), ARTHRALGIA (Joint pain) and VACCINATION SITE PAIN (Pain at the injection site). On an unknown date, the patient experienced VACCINATION COMPLICATION (Had all the general side effects listed for the last 2-3 days). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency. On 22-Jul-2021, MUSCULOSKELETAL STIFFNESS (Stiffness throughout body), MUSCULAR WEAKNESS (Weakness in the entire arm on injection side.), PYREXIA (low grade fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (General muscle pain), ARTHRALGIA (Joint pain) and VACCINATION SITE PAIN (Pain at the injection site) had resolved. At the time of the report, VACCINATION COMPLICATION (Had all the general side effects listed for the last 2-3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 13-Aug-2021: Significant follow up added on 13-Aug-2021, patient details height, weight and race, added batch number anatomical location, added events.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Myalgia, Nausea, Pyrexia, Vaccination complication
Clinical narrative: Had all the general side effects listed for the last 2-3 days; Stiffness throughout body; Weakness in the entire arm on injection side.; low grade fever; Chills; Nausea; Fatigue; Headache; General muscle pain; Joint pain; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had all the general side effects listed for the last 2-3 days), MUSCULOSKELETAL STIFFNESS (Stiffness throughout body), MUSCULAR WEAKNESS (Weakness in the entire arm on injection side.), PYREXIA (low grade fever) and CHILLS (Chills) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21CA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness throughout body), MUSCULAR WEAKNESS (Weakness in the entire arm on injection side.), PYREXIA (low grade fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (General muscle pain), ARTHRALGIA (Joint pain) and VACCINATION SITE PAIN (Pain at the injection site). On an unknown date, the patient experienced VACCINATION COMPLICATION (Had all the general side effects listed for the last 2-3 days). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency. On 22-Jul-2021, MUSCULOSKELETAL STIFFNESS (Stiffness throughout body), MUSCULAR WEAKNESS (Weakness in the entire arm on injection side.), PYREXIA (low grade fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (General muscle pain), ARTHRALGIA (Joint pain) and VACCINATION SITE PAIN (Pain at the injection site) had resolved. At the time of the report, VACCINATION COMPLICATION (Had all the general side effects listed for the last 2-3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 13-Aug-2021: Significant follow up added on 13-Aug-2021, patient details height, weight and race, added batch number anatomical location, added events.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Had all the general side effects listed for the last 2-3 days; Stiffness throughout body; Weakness in the entire arm on injection side.; low grade fever; Chills; Nausea; Fatigue; Headache; General muscle pain; Joint pain; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had all the general side effects listed for the last 2-3 days), MUSCULOSKELETAL STIFFNESS (Stiffness throughout body), MUSCULAR WEAKNESS (Weakness in the entire arm on injection side.), PYREXIA (low grade fever) and CHILLS (Chills) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21CA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness throughout body), MUSCULAR WEAKNESS (Weakness in the entire arm on injection side.), PYREXIA (low grade fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (General muscle pain), ARTHRALGIA (Joint pain) and VACCINATION SITE PAIN (Pain at the injection site). On an unknown date, the patient experienced VACCINATION COMPLICATION (Had all the general side effects listed for the last 2-3 days). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency. On 22-Jul-2021, MUSCULOSKELETAL STIFFNESS (Stiffness throughout body), MUSCULAR WEAKNESS (Weakness in the entire arm on injection side.), PYREXIA (low grade fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (General muscle pain), ARTHRALGIA (Joint pain) and VACCINATION SITE PAIN (Pain at the injection site) had resolved. At the time of the report, VACCINATION COMPLICATION (Had all the general side effects listed for the last 2-3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 13-Aug-2021: Significant follow up added on 13-Aug-2021, patient details height, weight and race, added batch number anatomical location, added events.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Back pain, Fatigue, Headache
Clinical narrative: back hurt; stomach hurt (she doubled over); rash on nose; arm hurt; shoulder hurt; bad headache; tired; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back hurt), ABDOMINAL PAIN UPPER (stomach hurt (she doubled over)), RASH (rash on nose), VACCINATION SITE PAIN (arm hurt) and ARTHRALGIA (shoulder hurt) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stomach discomfort (Motility issues in stomach), Stroke (3 stroks (1991, 2002, 2006).), Endometriosis, Psychiatric disorder NOS and High cholesterol. Concurrent medical conditions included Allergy (Allergies include all of the "lipitor class", all stomach medications.) and Allergy to sting (Allergy to bee sting). Concomitant products included CLONAZEPAM (KLONOPIN), CLOPIDOGREL BISULFATE (PLAVIX), OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]), VITAMINS NOS, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and ALFUZOSIN for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced BACK PAIN (back hurt), ABDOMINAL PAIN UPPER (stomach hurt (she doubled over)), RASH (rash on nose), VACCINATION SITE PAIN (arm hurt), ARTHRALGIA (shoulder hurt), HEADACHE (bad headache) and FATIGUE (tired). At the time of the report, BACK PAIN (back hurt), ABDOMINAL PAIN UPPER (stomach hurt (she doubled over)), RASH (rash on nose), VACCINATION SITE PAIN (arm hurt), ARTHRALGIA (shoulder hurt), HEADACHE (bad headache) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were reported.   This case was linked to MOD-2021-263735, MOD-2021-263805 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Aug-2021: Non-Significant follow up appended: No new information
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain
Clinical narrative: back hurt; stomach hurt (she doubled over); rash on nose; arm hurt; shoulder hurt; bad headache; tired; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back hurt), ABDOMINAL PAIN UPPER (stomach hurt (she doubled over)), RASH (rash on nose), VACCINATION SITE PAIN (arm hurt) and ARTHRALGIA (shoulder hurt) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stomach discomfort (Motility issues in stomach), Stroke (3 stroks (1991, 2002, 2006).), Endometriosis, Psychiatric disorder NOS and High cholesterol. Concurrent medical conditions included Allergy (Allergies include all of the "lipitor class", all stomach medications.) and Allergy to sting (Allergy to bee sting). Concomitant products included CLONAZEPAM (KLONOPIN), CLOPIDOGREL BISULFATE (PLAVIX), OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]), VITAMINS NOS, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and ALFUZOSIN for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced BACK PAIN (back hurt), ABDOMINAL PAIN UPPER (stomach hurt (she doubled over)), RASH (rash on nose), VACCINATION SITE PAIN (arm hurt), ARTHRALGIA (shoulder hurt), HEADACHE (bad headache) and FATIGUE (tired). At the time of the report, BACK PAIN (back hurt), ABDOMINAL PAIN UPPER (stomach hurt (she doubled over)), RASH (rash on nose), VACCINATION SITE PAIN (arm hurt), ARTHRALGIA (shoulder hurt), HEADACHE (bad headache) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were reported.   This case was linked to MOD-2021-263735, MOD-2021-263805 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Aug-2021: Non-Significant follow up appended: No new information
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Illness, Nausea, Product dose omission issue
Clinical narrative: Sick; felt like having a fever, no actual fever.; more than 36 days from first vaccination; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), FEELING ABNORMAL (felt like having a fever, no actual fever.), PRODUCT DOSE OMISSION ISSUE (more than 36 days from first vaccination) and NAUSEA (Nauseous) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     Concurrent medical conditions included Psoriasis. Concomitant products included METOPROLOL SUCCINATE for an unknown indication.    On 23-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick), FEELING ABNORMAL (felt like having a fever, no actual fever.), PRODUCT DOSE OMISSION ISSUE (more than 36 days from first vaccination) and NAUSEA (Nauseous). At the time of the report, ILLNESS (Sick), FEELING ABNORMAL (felt like having a fever, no actual fever.) and NAUSEA (Nauseous) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (more than 36 days from first vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient states she has BVC (no acronym provided) metoprolol succinate ER given for BVC. it was reported that patient was unable to get the second dose due to family issue.     Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Aug-2021: Followup information received wherein new event was updated.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Raised rash the size of a baseball at the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE RASH (Raised rash the size of a baseball at the injection site) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Patient medical history was not provided.  Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) and LISINOPRIL for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced VACCINATION SITE RASH (Raised rash the size of a baseball at the injection site). On 03-May-2021, VACCINATION SITE RASH (Raised rash the size of a baseball at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not reported.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Didn't receive second dose (9 weeks since first one); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Didn't receive second dose (9 weeks since first one)) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.  On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 23-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Didn't receive second dose (9 weeks since first one)).   On 23-Jul-2021, PRODUCT DOSE OMISSION ISSUE (Didn't receive second dose (9 weeks since first one)) had resolved.            Concomitant and treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Aug-2021: Follow up received contain second dose information and No adverse event after second dose
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drugs were reported.  No treatment medications were reported.   This case was linked to MOD21-109324, MOD21-109532, MOD21-109542, MOD21-109544, MOD21-109546, MOD21-109548, MOD21-109552, MOD21-109553, MOD21-109543 (Patient Link).; Sender's Comments: This report refers to a case of  Product administration error  for mRNA-1273, lot #  021C21A  with no associated AEs.
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue
Clinical narrative: I got my first shot today should I be short breath; I got my first shot today should I be tired; This spontaneous case was reported by a patient and describes the occurrence of DYSPNOEA (I got my first shot today should I be short breath) and FATIGUE (I got my first shot today should I be tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (I got my first shot today should I be short breath) and FATIGUE (I got my first shot today should I be tired). At the time of the report, DYSPNOEA (I got my first shot today should I be short breath) and FATIGUE (I got my first shot today should I be tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information provided.  No treatment information provided
Sex: U
Vaccine: COVID19
Symptoms: Adverse drug reaction, Musculoskeletal stiffness
Clinical narrative: leg stiffnes and pain; side effect; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (leg stiffnes and pain) and ADVERSE DRUG REACTION (side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (leg stiffnes and pain) and ADVERSE DRUG REACTION (side effect). At the time of the report, MUSCULOSKELETAL STIFFNESS (leg stiffnes and pain) and ADVERSE DRUG REACTION (side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Vaccine information was not provided. No treatment information was provided. No concomitant medication was provided.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: possibly got COVID after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (possibly got COVID after vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (possibly got COVID after vaccination). At the time of the report, COVID-19 (possibly got COVID after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not reported  Treatment information was not reported